The DRUG Act would limit how pharmacy benefit managers (PBMs) are paid for work related to prescription drug benefits. Starting January 1, 2027, PBMs generally could not receive remuneration for these activities. They could charge a flat fee under a written agreement for a bona fide service, priced at fair market value and not tied to drug prices, rebates, or other specified amounts. The bill would allow payments for drug ingredient costs and pharmacy dispensing fees, and would allow rebates and other price concessions to be passed through to health plans or insurers. It would require repayment of certain improper amounts and impose a $10,000 daily civil penalty for violations. The bill has been referred to House committees.
If you are covered by a group health plan or health insurance, the bill would change how PBMs may be paid for managing prescription drug benefits. It does not specify how those changes would affect an individual’s premiums or out-of-pocket costs.
The bill sets a $10,000-per-day penalty for continuing violations. No publicly available information on the bill’s overall cost or its effect on consumers’ expenses.
No publicly available information.
No publicly available information.